Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00864630 · ClinicalTrials.gov registry record · NA
Neuroimaging for Depression
A NA study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 68
- Enrollment target
NCT00864630: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT00864630 is a NA study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 68 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00864630, a NA study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
Study Summary
The investigators seek to determine whether brain imaging techniques can be used to help detect depression, assess its severity, and/or monitor or predict responses to treatment. Subjects with minor or major depression will be randomly assigned to a wait-list control group or to treatment with a new computer-based cognitive behavior therapy developed by Dr. James Cartriene. Brain imaging will be performed before and during treatment using both magnetic resonance imaging (MRI) and near-infrared spectroscopy (NIRS). The investigators hypothesize that brain activity, particularly in the lateral frontal areas of the brain, will provide biomarkers for depression, depression severity, and treatment response.
Interventions
- BEHAVIORAL Computer-based problem solving therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2010-09 |
| Est. Completion | 2011-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00864630
The ClinicalTrials.gov registry entry for NCT00864630 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Computer-based problem solving therapy is the first listed.
NCT00864630 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00864630 about?
NCT00864630 is a clinical study titled "Neuroimaging for Depression". The investigators seek to determine whether brain imaging techniques can be used to help detect depression, assess its severity, and/or monitor or predict responses to treatment. Subjects with minor or major depression will be randomly assigned to a wait-list control group or to treatment with a new...
What is the current status of trial NCT00864630?
This trial is currently terminated. It is a NA study. The enrollment target is 68 participants. The study started on 2010-09. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00864630?
The interventions under investigation include: Computer-based problem solving therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00864630?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.